Lv1
70 积分 2025-08-26 加入
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
Adjuvant Immunotherapy in Lung Cancer
5个月前
已关闭
Towards a personalized utilization of stereotactic body radiotherapy for the management of liver metastases in solid tumors
5个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
5个月前
已完结
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer
6个月前
已完结
Real-world survival outcomes of immune checkpoint inhibitor therapy after standard treatment failure in EGFR-mutated NSCLC: A nationwide cohort study
7个月前
已完结
皖公网安备34019202002308
